Zinc finger protein 722 (ZNF722)

Zinc finger protein 722 (ZNF722) is annotated as a member of the C2H2-type zinc finger protein family, which is a large group of transcription factors characterized by the presence of zinc finger domains that stabilize protein structure and enable DNA, RNA, or protein binding[1][2][5]. ZNF722 closely resembles KRAB-type zinc finger proteins, a subclass that typically represses gene transcription. However, ZNF722 is annotated as a pseudogene in several sources, indicating that it may not be expressed as a functional protein or could encode a non-functional product due to gene disruptions or duplications[2]. While zinc finger proteins in general play critical roles in transcriptional regulation, genome stability, and other cellular processes[1][5], there is no direct evidence that ZNF722 itself is a functional protein or clinically relevant therapeutic target. There are no drugs, disease roles, or biomarkers specifically associated with ZNF722 in the literature surveyed. Key points: - ZNF722 is most often classified as a pseudogene and not a protein-coding gene[2]. - It does not currently appear in databases as a validated therapeutic target, nor is it linked to specific drugs or human diseases. - The vast majority of C2H2 zinc finger proteins are transcription factors, but the pseudogene status of ZNF722 makes its function likely absent or uncertain in humans. Conclusion: ZNF722 is not a validated or likely therapeutic target. Due to its classification as a pseudogene, it is not a functional receptor, enzyme, transporter, or clinically actionable entity[2].

Other names

ZNF722ZNF722Pzinc finger protein 722zinc finger protein 722 pseudogenezinc finger protein 479 pseudogenepseudogene